Plain-English translation of NCT06275230 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to grow human lung stem cells in the laboratory and create miniature lung structures called organoids using tissue from people with COPD. By studying these lab-grown lung models, scientists hope to better understand how COPD develops and eventually find new ways to treat it.
Currently, there are limited ways for researchers to study how COPD damages the lungs in detail. By creating these miniature lung models from patient tissue, scientists can observe the disease process more closely and test new treatment ideas in a controlled setting.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo a bronchoscopy — a procedure you may already be scheduled for as part of your regular COPD care. During this procedure, doctors will collect a small lung tissue sample to use for growing cells in the laboratory. That's the main requirement; researchers will then grow and study your lung cells in the lab to advance understanding of COPD.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
China
Sponsor
China-Japan Friendship Hospital
Enrollment target
~30 participants
Started
March 2024
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 55 Years
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mingming Deng, MD
China-Japan Friendship Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.